BMY vs KOP · P/E 17, rev $24.46B vs P/E 28, rev $975.4M
Bristol-Myers Squibb Company (BMY) versus Koppers Holdings Inc (KOP) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US.
Koppers Holdings Inc (KOP) is a specialty chemicals company listed on US.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported KOP revenue for 2026-06-30 was $975.4M. Net income was -$140.4M. KOP currently screens at market cap $695.4M and trailing P/E 28.3.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. KOP currently screens at market cap $695.4M and trailing P/E 28.3.
Not investment advice. Open the BMY and KOP stock pages for the full models.
Not investment advice.